Study of pharmacodynamic and pharmacokinetic-mediated genetic susceptibility to drug-induced arrhythmia and sudden cardiac death

被引：0
|
作者：
Martinez-Matilla, M. [1 ]
Blanco-Verea, A. [1 ]
Torres, M. [2 ]
Ramos-Luis, E. [1 ]
Gil, R. [1 ]
Bermejo, A. [3 ]
Hirata, M. H. [4 ]
Brisighelli, F. [5 ]
Paramo, M. [6 ]
Carracedo, A. [7 ]
Brion, M. [1 ]
机构：
[1] USC, Inst Invest Sanitaria Santiago, Xenet Enfermidades Cardiovasc & Oftalmolox, Grp Med Xenom, Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, CeGen Genotyping Natl Ctr, Grp Med Xenom, Santiago De Compostela, Spain
[3] Univ Santiago de Compostela, Inst Ciencias Forens Luis Concheiro, INCIFOR, Santiago De Compostela, Spain
[4] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[5] Univ Cattolica Sacro Cuore, Forens Gen Lab, Inst Legal Med, Rome, Italy
[6] Univ Hosp Santiago de Compostela, Serv Psiquiatria, Santiago De Compostela, Spain
[7] Univ Santiago de Compostela USC, Inst Invest Sanitaria Santiago, Grp Med Xenom, Santiago De Compostela, Spain
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5857
引用
收藏
页码：1241 / 1241
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation
    Piotrovsky, V
    AAPS JOURNAL, 2005, 7 (03): : E609 - E624
  • [22] Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
    De Bruin, ML
    Pettersson, M
    Meyboom, RHB
    Hoes, AW
    Leufkens, HGM
    EUROPEAN HEART JOURNAL, 2005, 26 (06) : 590 - 597
  • [23] Drug-induced Genetic Mutation: a Descriptive Study
    Balaha, Mohamed
    Ahmed, Nehad
    Alahmari, Abdullah
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (12): : 2356 - 2359
  • [24] Methodology the ongoing drug-induced arrhythmia risk evaluation (DARE) study
    Marshall, V.
    Behr, E.
    Carter, N.
    Jeffrey, S.
    Shakir, S. A. W.
    Camm, A. J.
    DRUG SAFETY, 2006, 29 (10) : 964 - 964
  • [25] Methodology of the ongoing drug-induced arrhythmia risk evaluation (DARE) study
    Marshall, V.
    Behr, E.
    Carter, N.
    Jeffrey, S.
    Shakir, S. A. W.
    Camm, A. J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 773 - 774
  • [26] Cohort Description of the Drug-Induced Arrhythmia Risk Evaluation (DARE) Study
    Marshall, Vanessa
    Behr, Elijah
    Cornelius, Victoria
    Shakir, Saad
    Camm, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S33 - S33
  • [27] Cohort Description of the Drug-Induced Arrhythmia Risk Evaluation (DARE) Study
    Marshall, V.
    Behr, E.
    Jeffery, S.
    Shakir, S.
    Camm, J.
    DRUG SAFETY, 2010, 33 (10) : 899 - 899
  • [28] Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment
    Vitiello, Antonio
    Ferrara, Francesco
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [29] Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment
    Antonio Vitiello
    Francesco Ferrara
    The Egyptian Heart Journal, 73
  • [30] Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans
    Giudicessi, John R.
    Roden, Dan M.
    Wilde, Arthur A. M.
    Ackerman, Michael J.
    HEART RHYTHM, 2020, 17 (09) : 1487 - 1492
12345